Classes & Events News Get
Updates
Donate

Mahalaxmi Aburi

Vice President, Research

Dr. Mahalaxmi Aburi is the Vice President of Research at Atlantic Health System. She has built a more than 12-year career in leading strategy and implementation of innovative healthcare programs spanning several segments of research and healthcare administration to modernize care delivery. As Vice President of Research, Dr. Aburi is responsible for conceptualizing, developing, and implementing Atlantic Health System’s research growth strategy for clinical innovation, positioning Atlantic Health System as a leading healthcare system in the highly competitive New Jersey market. In her role, she also provides oversight of all research administration offices within Atlantic Center for Research.

Dr. Aburi joined Atlantic Health System in 2020 as the director of the Atlantic Center for Research. In the past three years, she has significantly elevated Atlantic Health System’s research mission by expanding our research portfolio and has developed critical relationships within and outside the organization to drive the vision for research. Dr. Aburi has also led the development of novel collaborations with academic and biotech partners.

Prior to joining Atlantic Health System, Dr. Aburi was the Executive Director of Precision Cancer Medicine Program in Systems Biology at Columbia University Irving Medical Center (CUIMC). She oversaw the inception of a unique multi-institution, multi-investigator, program built on paradigm shifting partnerships and interdisciplinary collaborations within academia, industry, and foundations. The program aimed to leverage innovative, model-based methodologies and technologies to implement novel precision medicine strategies and to translate them to clinic.

Dr. Aburi has also held the roles of executive director and scientific operations manager at CUIMC as well as of faculty development specialist at NYU School of Medicine. Dr. Aburi has a PhD in Computational Drug Design from Kansas State University. She did her postdoctoral work in Neuropharmacology at CUIMC. She also has a Master of Healthcare Administration from Columbia University’s Mailman School of Public Health.